Advertisements



Onconova Therapeutics stock drops 12% after pricing stock offering

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchApr 21st, 2017

Onconova Therapeutics prices $2.5 mln stock offering at $2.10 a share

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchApr 21st, 2017

Cara Therapeutics Announces Pricing for Secondary Offering

Cara Therapeutics has priced more than 4 million shares of common stock at $18 per share in a secondary offering valued up to around $92 million......»»

Category: blogSource: 247wallstMar 31st, 2017

Sangamo"s stock plunges after large stock offering priced well below recent prices

Shares of Sangamo Therapeutics Inc. tumbled 9.8% in premarket trade Wednesday, after the developer for genomic therapies priced a public offering of common stock well below the previous session's clos.....»»

Category: topSource: marketwatchJun 21st, 2017

Aldeyra Therapeutics stock drops 16% after mid-stage trial miss

Aldeyra Therapeutics Inc. shares dropped 16.2% in heavy morning trade Wednesday after the company said its allergic conjunctivitis drug missed its primary endpoint in a mid-stage clinical trial. Still, the company said it planned to move the drug fo.....»»

Category: topSource: marketwatchJun 14th, 2017

Aldeyra Therapeutics stock drops 16% after mid-stage conjunctivitis trial misses primary endpoint

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJun 14th, 2017

Athenex"s Stock To Debut On The Nasdaq After Pricing IPO To Raise $66 Million

Athenex Inc. said Wednesday it priced its initial public offering of 6 million shares at $11 a share to raise $66 million......»»

Category: topSource: foxnewsJun 14th, 2017

Athenex"s stock to debut on the Nasdaq after pricing IPO to raise $66 million

Athenex Inc. said Wednesday it priced its initial public offering of 6 million shares at $11 a .....»»

Category: topSource: marketwatchJun 14th, 2017

Juno Therapeutics stock drops 5% after BTIG downgrades to sell

Juno Therapeutics Inc. shares dropped 5.2% in premarket trade Thursday after BTIG downgraded it.....»»

Category: topSource: marketwatchJun 8th, 2017

Juno Therapeutics stock drops 5% after BTIG downgrades to sell

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJun 8th, 2017

UPDATE: Onconova Therapeutics stock surges 7% on positive mid-stage clinical trial results

Onconova Therapeutics Inc. stock surged 7% in morning trade Monday after the company said its drug had positive results in a mid-stage clinical trial for patients with higher-risk myelodysplastic syndromes, conditions that are considered a .....»»

Category: topSource: marketwatchJun 5th, 2017

Onconova Therapeutics stock surges 11.5% on positive mid-stage clinical trial results

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJun 5th, 2017

Why Did Cara Therapeutics Shares Tumble 13.6% in April?

Investors sold off shares in the pain-drug developer following a stock offering, and ahead of first-quarter earnings......»»

Category: topSource: foxnewsMay 6th, 2017

Edge Therapeutics Rises Following Registered Direct Offering Announcement

Shares of Edge Therapeutics posted a solid gain in Wednesday’s trading session after the company announced that it would be conducting a registered direct offering of its common stock......»»

Category: blogSource: 247wallstApr 19th, 2017

Sorrento"s stock plunges on heavy volume after stock offering prices at deep discount

Shares of Sorrento Therapeutics Inc. plunged 36% toward a 4 1/2-year low in active morning trade Thursday, after the cance.....»»

Category: topSource: marketwatchApr 13th, 2017

Cadence Bank parent prices IPO at midpoint, to begin trading

Cadence Bancorporation begins trading on the New York Stock Exchange under the symbol “CADE” April 13 after pricing its initial public offering at the midpoint of the expected range. The Houston-based holding company for Cadence Bank priced its .....»»

Category: topSource: bizjournalsApr 13th, 2017

Proposed Stock Offering Sinks Sorrento Therapeutics Inc (SRNE)

Shares of Sorrento Therapeutics Inc (NASDAQ:SRNE) have fallen 22% in extended-market trading after the biopharmaceutical company announced .....»»

Category: topSource: insidermonkeyApr 12th, 2017

Cytori Therapeutics" stock plunges toward record low after stock offering prices at deep discount

S.....»»

Category: topSource: marketwatchApr 11th, 2017

Onconova Therapeutics stock surges 18% on positive pre-clinical data for cancer drugs

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchApr 4th, 2017

Evolent Health (EVH) Prices 7.5M Follow-On Share Offering

Evolent Health, Inc. (EVH) announced the pricing of its follow-on public offering of 7.5 million shares of Class A common stock at $21.25 per share. Provider of integrated value-based.....»»

Category: topSource: zacksMar 28th, 2017

Tesla Defies Gravity With More Capital Being Raised

When most companies announce a secondary offering of stock along with convertible senior notes, the share price drops. Tesla is not most companies......»»

Category: blogSource: 247wallstMar 16th, 2017